72TiP AVALON trial: Phase IIb study of maveropepimut-s and low-dose cyclophosphamide in subjects with platinum-resistant, epithelial ovarian cancer
| Autor: | Dorigo, O., Chalas, E., Iglesias, J.L., Fiset, S., MacDonald, L.D., Hirsch, H., Mody, K., Graff, J. |
|---|---|
| Zdroj: | In ESMO Open February 2023 8(1) Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|